Lido Advisors’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Buy
5,667
+814
+17% +$41.8K ﹤0.01% 1800
2026
Q1
$288K Buy
4,853
+1,075
+28% +$69.7K ﹤0.01% 1590
2025
Q4
$235K Buy
3,778
+192
+5% +$11.8K ﹤0.01% 1693
2025
Q3
$224K Buy
3,586
+98
+3% +$6.82K ﹤0.01% 1632
2025
Q2
$279K Buy
3,488
+649
+23% +$54.3K ﹤0.01% 1375
2025
Q1
$244K Sell
2,839
-58
-2% -$4.76K ﹤0.01% 1297
2024
Q4
$226K Buy
+2,897
New +$225K ﹤0.01% 1335
2024
Q3
Sell
-4,057
Closed -$279K 1533
2024
Q2
$279K Sell
4,057
-338
-8% -$22.9K ﹤0.01% 1160
2024
Q1
$319K Buy
4,395
+154
+4% +$10.3K ﹤0.01% 1062
2023
Q4
$260K Buy
+4,241
New +$252K ﹤0.01% 1102
2022
Q2
Sell
-6,451
Closed -$341K 1032
2022
Q1
$341K Buy
+6,451
New +$372K ﹤0.01% 759
2020
Q2
Sell
-5,650
Closed -$207K 647
2020
Q1
$207K Buy
+5,650
New +$219K 0.01% 514

Other funds holding PBH

Lido Advisors's PBH Position: Q2 2026 in Review

Lido Advisors increased its Prestige Consumer Healthcare (PBH) stake by 17% in Q2 2026, buying an estimated $41.8K and bringing the position to 5,667 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

Lido Advisors first reported a position in PBH in Q1 2020 and has held it in 12 quarters since. The position peaked at $341K in Q1 2022. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Lido Advisors held 5,667 shares of Prestige Consumer Healthcare worth $268K as of Q2 2026.
  • Lido Advisors bought 814 Prestige Consumer Healthcare shares in Q2 2026, an estimated $41.8K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Lido Advisors's portfolio in Q2 2026, its #1800 holding.
  • Lido Advisors first reported a position in Prestige Consumer Healthcare in Q1 2020 and has held it in 12 quarters since.
  • Lido Advisors's Prestige Consumer Healthcare position peaked at $341K in Q1 2022.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.